OxyContin maker Purdue Pharma has agreed to pay $20 million to settle a class-action lawsuit involving allegations about how the pain pills were marketed. "A Canada-wide settlement has been reached in a long-standing class action based on allegations relating to OxyContin. By resolving the suit, Purdue Pharma (Canada) makes no admissions of liability," Sarah Manley Robertson, director of communications, said in an email on Monday. The settlement totals $20 million with $2 million allocated to provincial health providers, Wagner said. It took my worries away and cares away and at the end of it, it near took my life away."

Source: CBC News May 01, 2017 18:39 UTC